High Tower Advisors, LLC Pacific Biosciences Of California, Inc. Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 16,598 shares of PACB stock, worth $32,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,598

Previous 24,916 33.38%

Holding current value

$32,034

Previous $34,000 17.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.2 - $2.17 $9,981 - $18,050	-8,318 Reduced 33.38%	16,598 $28,000
Q2 2024 Aug 13, 2024	SELL	$1.36 - $3.65 $26,526 - $71,193	-19,505 Reduced 43.91%	24,916 $34,000
Q1 2024 May 06, 2024	SELL	$3.52 - $9.59 $7,518 - $20,484	-2,136 Reduced 4.59%	44,421 $166,000
Q4 2023 Feb 12, 2024	SELL	$5.97 - $10.36 $152,473 - $264,594	-25,540 Reduced 35.42%	46,557 $456,000
Q3 2023 Nov 08, 2023	SELL	$8.23 - $13.93 $51,388 - $86,978	-6,244 Reduced 7.97%	72,097 $602,000
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $115,303 - $162,488	-11,565 Reduced 12.86%	78,341 $1.04 Million
Q1 2023 May 11, 2023	BUY	$7.94 - $12.02 $25,273 - $38,259	3,183 Added 3.67%	89,906 $1.04 Million
Q4 2022 Feb 08, 2023	SELL	$5.67 - $11.2 $121,423 - $239,847	-21,415 Reduced 19.8%	86,723 $709,000
Q3 2022 Nov 09, 2022	SELL	$3.93 - $8.57 $205,480 - $448,082	-52,285 Reduced 32.59%	108,138 $630,000
Q2 2022 Aug 10, 2022	SELL	$4.02 - $10.43 $193,892 - $503,059	-48,232 Reduced 23.12%	160,423 $703,000
Q1 2022 May 12, 2022	BUY	$8.43 - $20.9 $992,801 - $2.46 Million	117,770 Added 129.58%	208,655 $1.9 Million
Q4 2021 Feb 10, 2022	BUY	$19.26 - $30.08 $185,781 - $290,151	9,646 Added 11.87%	90,885 $1.86 Million
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $32,840 - $46,261	-1,321 Reduced 1.6%	81,239 $2.08 Million
Q2 2021 Aug 06, 2021	SELL	$22.3 - $36.02 $228,641 - $369,313	-10,253 Reduced 11.05%	82,560 $2.89 Million
Q1 2021 May 10, 2021	BUY	$26.38 - $51.15 $2.07 Million - $4.02 Million	78,513 Added 549.04%	92,813 $3.09 Million
Q4 2020 Feb 10, 2021	BUY	$10.5 - $28.5 $150,150 - $407,550	14,300 New	14,300 $371,000
Q3 2017 Nov 14, 2017	SELL	$3.2 - $5.57 $88,912 - $154,762	-27,785 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	27,785	27,785 $101,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $434M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Pacific Biosciences Of California, Inc. Transaction History